• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-环丝氨酸治疗阿尔茨海默病的初步研究。

A preliminary study of D-cycloserine treatment in Alzheimer's disease.

作者信息

Tsai G E, Falk W E, Gunther J

机构信息

Geriatric Neurobehavioral Clinic, Massachusetts General Hospital, Charlestown, USA.

出版信息

J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):224-6. doi: 10.1176/jnp.10.2.224.

DOI:10.1176/jnp.10.2.224
PMID:9608414
Abstract

D-cycloserine is a partial agonist on the glycine site of the N-methyl-D-aspartate glutamate receptor. This double-blind crossover study of 15 mg D-cycloserine in Alzheimer's disease patients did not demonstrate clinical benefit. Higher medication dosage or long-term treatment may be required.

摘要

D-环丝氨酸是N-甲基-D-天冬氨酸谷氨酸受体甘氨酸位点上的部分激动剂。这项针对阿尔茨海默病患者使用15毫克D-环丝氨酸的双盲交叉研究未显示出临床益处。可能需要更高的药物剂量或长期治疗。

相似文献

1
A preliminary study of D-cycloserine treatment in Alzheimer's disease.D-环丝氨酸治疗阿尔茨海默病的初步研究。
J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):224-6. doi: 10.1176/jnp.10.2.224.
2
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.短期D-环丝氨酸治疗改善阿尔茨海默病的认知功能
Am J Psychiatry. 1999 Mar;156(3):467-9. doi: 10.1176/ajp.156.3.467.
3
Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.D-环丝氨酸治疗创伤后应激障碍的试点对照试验。
Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061.
4
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.在精神分裂症阴性症状治疗中,将D-环丝氨酸添加到抗精神病药物中的剂量探索试验。
Am J Psychiatry. 1995 Aug;152(8):1213-5. doi: 10.1176/ajp.152.8.1213.
5
A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.一项针对精神分裂症患者,在氯氮平基础上加用D-环丝氨酸的安慰剂对照交叉试验。
Biol Psychiatry. 1999 Feb 15;45(4):512-4. doi: 10.1016/s0006-3223(98)00367-9.
6
D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.D-环丝氨酸增强暴露疗法治疗强迫症。
Biol Psychiatry. 2007 Oct 15;62(8):835-8. doi: 10.1016/j.biopsych.2006.12.020. Epub 2007 Jun 22.
7
d-Cycloserine enhances implicit memory in Alzheimer patients.D-环丝氨酸可增强阿尔茨海默病患者的内隐记忆。
Neurology. 1996 Feb;46(2):420-4. doi: 10.1212/wnl.46.2.420.
8
D-cycloserine treatment of Alzheimer disease.D-环丝氨酸治疗阿尔茨海默病。
Alzheimer Dis Assoc Disord. 1994 Fall;8(3):198-205. doi: 10.1097/00002093-199408030-00006.
9
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review.D-环丝氨酸在神经精神疾病中的应用:一项系统评价。
Int J Neuropsychopharmacol. 2016 Apr 20;19(4). doi: 10.1093/ijnp/pyv102. Print 2016 Apr.
10
D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.D-环丝氨酸辅助暴露疗法可改善神经性厌食症患者的体重反弹:一项初步随机对照试验。
J Clin Psychiatry. 2015 Jun;76(6):e787-93. doi: 10.4088/JCP.14m09299.

引用本文的文献

1
The synergistic effects of cycloserine and anodal tDCS: a systematic review and meta-analysis.环丝氨酸与阳极经颅直流电刺激的协同作用:一项系统评价与荟萃分析。
Exp Brain Res. 2025 Mar 18;243(4):94. doi: 10.1007/s00221-025-07038-3.
2
Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems.D-环丝氨酸纳米晶形式的制备及其在透皮和肠溶药物递送系统中的应用。
Beilstein J Nanotechnol. 2024 Apr 25;15:465-474. doi: 10.3762/bjnano.15.42. eCollection 2024.
3
Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer's disease: and studies.
评估D-环丝氨酸和L-丝氨酸在氯化铝诱导的阿尔茨海默病实验模型中的神经保护潜力:以及 研究。 (原文中“and studies”部分表述不完整,可能影响准确理解)
Front Nutr. 2022 Sep 8;9:981889. doi: 10.3389/fnut.2022.981889. eCollection 2022.
4
The gut microbiome and Alzheimer's disease: Complex and bidirectional interactions.肠道微生物组与阿尔茨海默病:复杂且双向的相互作用。
Neurosci Biobehav Rev. 2022 Oct;141:104814. doi: 10.1016/j.neubiorev.2022.104814. Epub 2022 Aug 4.
5
Effect of N-methyl-D-aspartate receptor enhancing agents on cognition in dementia: an exploratory systematic review and meta-analysis of randomized controlled trials.N-甲基-D-天冬氨酸受体增强剂对痴呆认知功能的影响:一项随机对照试验的探索性系统评价和荟萃分析。
Sci Rep. 2021 Nov 26;11(1):22996. doi: 10.1038/s41598-021-02040-5.
6
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress.阿尔茨海默病的新型生物标志物:基于N-甲基-D-天冬氨酸受体低激活和氧化应激
Clin Psychopharmacol Neurosci. 2021 Aug 31;19(3):423-433. doi: 10.9758/cpn.2021.19.3.423.
7
Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease.肠道微生物群在阿尔茨海默病免疫变化中的作用。
Front Immunol. 2021 May 31;12:683068. doi: 10.3389/fimmu.2021.683068. eCollection 2021.
8
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease.胆碱能、肾上腺素能和谷氨酸能网络调节与阿尔茨海默病认知功能障碍的关系。
Int J Mol Sci. 2021 Feb 25;22(5):2283. doi: 10.3390/ijms22052283.
9
The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia.N-甲基-D-天冬氨酸受体神经传递与精准医学在痴呆行为和心理症状中的作用
Front Pharmacol. 2019 May 22;10:540. doi: 10.3389/fphar.2019.00540. eCollection 2019.
10
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.NMDA 神经传递功能障碍与阿尔茨海默病的行为和心理症状。
Curr Neuropharmacol. 2012 Sep;10(3):272-85. doi: 10.2174/157015912803217288.